NCT01253083

Brief Summary

Background: \- People who have cerebral palsy often have difficulty walking and moving their legs. Cerebral palsy is sometimes not identified until a child is almost 2 years of age, which means that early motor skill development can be affected and can have repercussions for later development. Studies in adults with neurological injuries (e.g., stroke, spinal cord injury) have shown that it is important to start intensive therapy soon after the injury, and it may be true that starting intensive therapy at a young age will be helpful for children with cerebral palsy. Researchers are interested in testing the effectiveness of a special body weight support system for mobility training in young children who have or are at risk for cerebral palsy. Objectives: \- To study the effectiveness of a mobility training program on the motor skills of young children who have or are at risk for cerebral palsy. Eligibility: \- Children between 12 and 36 months of age who have delayed motor skills and either have been diagnosed with cerebral palsy or show evidence of spasticity or brain damage. Design:

  • This study involves two 6-week study phases: a baseline phase and a mobility training program.
  • Participants will be screened with a physical examination and medical history.
  • During the baseline phase, participants will have mobility testing sessions once every 2 weeks. These tests will measure motor development and ability, including ease and speed of walking.
  • Participants' parents/guardians will receive a mobility sensor for the child to wear at home for at least 6 hours (awake time) to measure activity and mobility levels outside of the testing sessions.
  • After 6 weeks of baseline testing, participants will have 6 weeks of mobility training for 30 minutes 3 days per week. Training will involve motor tasks with weight support, conducted by a pediatric physical therapist. Activities may include walking, climbing inclines or steps, or squatting to reach toys. All sessions will be videotaped.
  • To evaluate the effects of the therapy program, participants will have testing sessions every 2 weeks.
  • Parents/guardians will also complete questionnaires to provide feedback on the effectiveness of the therapy program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Nov 2010

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2010

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

December 2, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 3, 2010

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 6, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2014

Completed
Last Updated

December 17, 2019

Status Verified

April 14, 2016

Enrollment Period

3.6 years

First QC Date

December 2, 2010

Last Update Submit

December 14, 2019

Conditions

Keywords

MobilityDevelopmental DelayCerebral PalsyEarly WalkingPostural Control

Outcome Measures

Primary Outcomes (1)

  • Change in motor delay

Secondary Outcomes (1)

  • Completion rate, change in gross motor function, change in functional mobility, change in walking speed, change in physical activity

Interventions

Eligibility Criteria

Age12 Months - 36 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • months of age
  • greater than or equal to 4 months of gross motor delay corrected for gestational age (measured by Bayley Motor Scale)
  • Diagnosis of bilateral spastic cerebral palsy OR neurological evidence of spasticity or brain damage
  • Ability to pull to stand at a surface without assistance
  • Cognitive ability to follow one-step commands
  • Availability to return to NIH CC with parent or caregiver for required treatment and assessment sessions

You may not qualify if:

  • Unilateral cerebral palsy
  • Secondary orthopedic, neuromuscular or cardiovascular condition unrelated to CP
  • Greater than six months of independent walking experience
  • History of surgery or injury to the lower extremities in the past 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Publications (3)

  • Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007 Feb;109:8-14.

    PMID: 17370477BACKGROUND
  • Yeargin-Allsopp M, Van Naarden Braun K, Doernberg NS, Benedict RE, Kirby RS, Durkin MS. Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration. Pediatrics. 2008 Mar;121(3):547-54. doi: 10.1542/peds.2007-1270.

    PMID: 18310204BACKGROUND
  • Odding E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil. 2006 Feb 28;28(4):183-91. doi: 10.1080/09638280500158422.

    PMID: 16467053BACKGROUND

MeSH Terms

Conditions

Learning DisabilitiesCerebral Palsy

Condition Hierarchy (Ancestors)

Communication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental DisordersBrain Damage, ChronicBrain DiseasesCentral Nervous System Diseases

Study Officials

  • Diane L Damiano, Ph.D.

    National Institutes of Health Clinical Center (CC)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2010

First Posted

December 3, 2010

Study Start

November 15, 2010

Primary Completion

June 6, 2014

Study Completion

June 6, 2014

Last Updated

December 17, 2019

Record last verified: 2016-04-14

Locations